|
Biofil Chemicals & Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
68.56 Cr.
|
P/BV
|
3.22
|
Book Value (Rs.)
|
13.09
|
|
52 Week High/Low (Rs.)
|
57/29
|
FV/ML
|
10/1
|
P/E(X)
|
123.19
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.34
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.34 | 0.44 | 0.34 | 0.44 | 0.76 |
| Diluted EPS (Rs.) | 0.34 | 0.44 | 0.34 | 0.44 | 0.76 |
| Cash EPS (Rs.) | 0.57 | 0.68 | 0.60 | 0.69 | 1.01 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 11.54 | 11.19 | 10.63 | 10.35 | 9.91 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 11.54 | 11.19 | 10.63 | 10.35 | 9.91 |
| Revenue From Operations / Share (Rs.) | 20.52 | 24.60 | 18.46 | 13.75 | 21.97 |
| PBDIT / Share (Rs.) | 0.70 | 0.80 | 0.77 | 0.91 | 1.47 |
| PBIT / Share (Rs.) | 0.47 | 0.55 | 0.51 | 0.64 | 1.22 |
| PBT / Share (Rs.) | 0.45 | 0.53 | 0.48 | 0.62 | 1.18 |
| Net Profit / Share (Rs.) | 0.34 | 0.43 | 0.34 | 0.42 | 0.76 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 3.45 | 3.26 | 4.21 | 6.62 | 6.71 |
| PBIT Margin (%) | 2.31 | 2.26 | 2.78 | 4.71 | 5.55 |
| PBT Margin (%) | 2.20 | 2.16 | 2.64 | 4.53 | 5.36 |
| Net Profit Margin (%) | 1.66 | 1.77 | 1.86 | 3.12 | 3.47 |
| Return on Networth / Equity (%) | 2.96 | 3.89 | 3.23 | 4.14 | 7.69 |
| Return on Capital Employeed (%) | 4.04 | 4.88 | 4.72 | 6.12 | 12.05 |
| Return On Assets (%) | 1.09 | 1.50 | 1.78 | 3.72 | 3.73 |
| Total Debt / Equity (X) | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 |
| Asset Turnover Ratio (%) | 0.68 | 1.02 | 1.20 | 0.86 | 0.94 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.34 | 1.35 | 1.63 | 6.23 | 1.40 |
| Quick Ratio (X) | 1.23 | 1.26 | 1.54 | 5.37 | 1.14 |
| Inventory Turnover Ratio (X) | 11.34 | 2.79 | 3.13 | 0.80 | 2.27 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 31.24 | 31.47 | 29.76 | 36.53 | 35.23 |
| Interest Coverage Ratio (Post Tax) (%) | 16.11 | 18.09 | 14.19 | 18.20 | 19.23 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 67.15 | 96.38 | 67.93 | 94.38 | 106.83 |
| EV / Net Operating Revenue (X) | 2.01 | 2.41 | 2.26 | 4.22 | 2.99 |
| EV / EBITDA (X) | 58.26 | 73.79 | 53.71 | 63.64 | 44.53 |
| MarketCap / Net Operating Revenue (X) | 2.00 | 2.45 | 2.25 | 4.20 | 2.99 |
| Price / BV (X) | 3.56 | 5.40 | 3.90 | 5.59 | 6.62 |
| Price / Net Operating Revenue (X) | 2.00 | 2.45 | 2.25 | 4.20 | 2.99 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
